number;agent;group;volume;year;informations
50-00-0;Formaldehyde;1;Sup 7, 62, 88, 100F;2012;
50-06-6;Phenobarbital;2B;Sup 7, 79;2001;
50-07-7;Mitomycin C;2B;10, Sup 7;1987;
"50-18-0
6055-19-2";Cyclophosphamide;1;26, Sup 7, 100A;2012;
50-29-3;DDT (4,4'-Dichlorodiphenyltrichloroethane);2A;Sup 7, 53, 113;2016 online;
50-32-8;Benzo[<i>a</i>]pyrene;1;Sup 7, 92, 100F;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
50-33-9;Phenylbutazone;3;13, Sup 7;1987;
50-41-9;Clomiphene citrate;3;21, Sup 7;1987;
50-44-2;6-Mercaptopurine;3;26, Sup 7;1987;
50-55-5;Reserpine;3;24, Sup 7;1987;
50-76-0;Actinomycin D;3;10, Sup 7;1987;
51-02-5;Pronetalol hydrochloride;3;13, Sup 7;1987;
51-03-6;Piperonyl butoxide;3;30, Sup 7;1987;
51-18-3;2,4,6-Tris(1-aziridinyl)-<i>s</i>-triazine;3;9, Sup 7;1987;
51-21-8;5-Fluorouracil;3;26, Sup 7;1987;
51-52-5;Propylthiouracil;2B;Sup 7, 79;2001;
51-75-2;Nitrogen mustard;2A;9, Sup 7;1987;
51-79-6;Ethyl carbamate (Urethane);2A;7, Sup 7, 96;2010;
52-01-7;Spironolactone;3;Sup 7, 79;2001;
52-24-4;Thiotepa;1;Sup 7, 50, 100A;2012;
52-46-0;Apholate;3;9, Sup 7;1987;
52-68-6;Trichlorfon;3;30, Sup 7;1987;
53-03-2;Prednisone;3;26, Sup 7;1987;
53-70-3;Dibenz[<i>a</i>,<i>h</i>]anthracene;2A;Sup 7, 92;2010;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
54-05-7;Chloroquine;3;13, Sup 7;1987;
54-31-9;Furosemide (Frusemide);3;50;1990;
54-85-3;Isonicotinic acid hydrazide (Isoniazid);3;4, Sup 7;1987;
55-18-5;<i>N</i>-Nitrosodiethylamine;2A;17, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
55-98-1;1,4-Butanediol dimethanesulfonate (see Busulfan);;;;
55-98-1;Busulfan;1;4, Sup 7, 100A;2012;
55-98-1;Myleran (see Busulfan);;;;
56-04-2;Methylthiouracil;2B;Sup 7, 79;2001;
56-23-5;Carbon tetrachloride;2B;20, Sup 7, 71;1999;
56-25-7;Cantharidin;3;10, Sup 7;1987;
56-38-2;Parathion;2B;30, Sup 7, 112;2017 online;
56-53-1;Diethylstilbestrol;1;21, Sup 7, 100A;2012;
56-55-3;Benz[<i>a</i>]anthracene;2B;92, Sup 7;2010;
56-75-7;Chloramphenicol;2A;Sup 7, 50;1990;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
57-06-7;Allyl isothiocyanate;3;73, Sup 7;1999;
57-14-7;1,1-Dimethylhydrazine;2B;4, Sup 7, 71;1999;
57-39-6;Tris(2-methyl-1-aziridinyl)phosphine oxide;3;9, Sup 7;1987;
57-41-0;Phenytoin;2B;Sup 7, 66;1996;
57-57-8;beta-Propiolactone;2B;4, Sup 7, 71;1999;
57-68-1;Sulfamethazine;3;79;2001;NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
57-74-9;Chlordane;2B;Sup 7, 53, 79;2001;
57-88-5;Cholesterol;3;31, Sup 7;1987;
58-08-2;Caffeine;3;51;1991;
58-14-0;Pyrimethamine;3;13, Sup 7;1987;
58-55-9;Theophylline;3;51;1991;
58-89-9;Lindane (see also Hexachlorocyclohexanes);1;113;In prep.;
58-93-5;Hydrochlorothiazide;2B;50, 108;2016;
59-05-2;Methotrexate;3;26, Sup 7;1987;
59-87-0;Nitrofural (Nitrofurazone);3;50;1990;
59-89-2;<i>N</i>-Nitrosomorpholine;2B;17, Sup 7;1987;
60-09-3;<i>para</i>-Aminoazobenzene;2B;8, Sup 7;1987;
60-11-7;<i>para</i>-Dimethylaminoazobenzene;2B;8, Sup 7;1987;
60-35-5;Acetamide;2B;7, Sup 7, 71;1999;
60-56-0;Methimazole;3;79;2001;
60-57-1;Dieldrin (see Dieldrin, and aldrin metabolized to dieldrin);;;;
60-57-1, 309-00-2;Dieldrin, and aldrin metabolized to dieldrin;2A;5, Sup 7, 117;In prep.;
61-57-4;Niridazole;2B;13, Sup 7;1987;
61-82-5;Amitrole;3;79, Sup 7;2001;NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
62-44-2;Phenacetin;1;24, Sup 7, 100A;2012;NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
62-50-0;Ethyl methanesulfonate;2B;7, Sup 7;1987;
62-53-3;Aniline;3;27, Sup 7;1987;
62-55-5;Thioacetamide;2B;7, Sup 7;1987;
62-56-6;Thiourea;3;Sup 7, 79;2001;
62-73-7;Dichlorvos;2B;Sup 7, 53;1991;
62-75-9;<i>N</i>-Nitrosodimethylamine;2A;17, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
63-25-2;Carbaryl;3;12, Sup 7;1987;
63-92-3;Phenoxybenzamine hydrochloride;2B;24, Sup 7;1987;
64-17-5;Ethanol in alcoholic beverages;1;96, 100E;2012;
64-67-5;Diethyl sulfate;2A;54, 71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
66-27-3;Methyl methanesulfonate;2A;7, Sup 7,  71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
66-75-1;Uracil mustard;2B;9, Sup 7;1987;
67-20-9;Nitrofurantoin;3;50;1990;
67-45-8;Furazolidone;3;31, Sup 7;1987;
67-63-0;Isopropyl alcohol;3;15, Sup 7, 71;1999;
67-66-3;Chloroform;2B;Sup 7, 73;1999;
67-72-1;Hexachloroethane;2B;73;1999;
68-12-2;Dimethylformamide;2A;47, 71, 115;In prep.;
68-76-8;Tris(aziridinyl)-<i>para</i>-benzoquinone (Triaziquone);3;9, Sup 7;1987;
69-53-4;Ampicillin;3;50;1990;
70-25-7;<i>N</i>-Methyl-<i>N</i>´-nitro-<i>N</i>-nitrosoguanidine (MNNG);2A;4, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
70-30-4;Hexachlorophene;3;20, Sup 7;1987;
71-43-2;Benzene;1;29, Sup 7. 100F;2012;
71-55-6;1,1,1-Trichloroethane;3;20, Sup 7, 71;1999;
71-58-9;Medroxyprogesterone acetate;2B;21, Sup 7;1987;
72-20-8;Endrin;3;5, Sup 7;1987;
72-43-5;Methoxychlor;3;20, Sup 7;1987;
72-57-1;Trypan blue;2B;8, Sup 7;1987;
74-83-9;Methyl bromide;3;41, Sup 7, 71;1999;
74-85-1;Ethylene;3;Sup 7, 60;1994;
74-87-3;Methyl chloride;3;41, Sup 7, 71;1999;
74-88-4;Methyl iodide;3;41, Sup 7, 71;1999;
74-96-4;Bromoethane;3;52, 71;1999;
75-00-3;Chloroethane;3;52, 71;1999;
75-01-4;Vinyl chloride;1;Sup 7, 97, 100F;2012;
75-02-5;Vinyl fluoride;2A;Sup 7, 63, 97;2008;"NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data;
(2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride"
75-07-0;Acetaldehyde;2B;36, Sup 7, 71;1999;
75-07-0;Acetaldehyde associated with consumption of alcoholic beverages;1;100E;2012;
75-09-2;Dichloromethane (Methylene chloride);2A;Sup 7, 71, 110;2016 online;
75-21-8;Ethylene oxide;1;Sup 7, 60, 97, 100F;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
75-25-2;Bromoform;3;52, 71;1999;
75-27-4;Bromodichloromethane;2B;52, 71;1999;
75-35-4;Vinylidene chloride;3;39, Sup 7, 71;1999;
75-38-7;Vinylidene fluoride;3;39, Sup 7, 71;1999;
75-45-6;Chlorodifluoromethane;3;41, Sup 7, 71;1999;
75-52-5;Nitromethane;2B;77;2000;
75-55-8;2-Methylaziridine (Propyleneimine);2B;9, Sup 7, 71;1999;
75-56-9;Propylene oxide;2B;Sup 7, 60;1994;
75-60-5;Dimethylarsinic acid;2B;100C;2012;
75-87-6;Chloral;2A;63, 84, 106;2014;
75-88-7;2-Chloro-1,1,1-trifluoroethane;3;41, Sup 7, 71;1999;
76-01-7;Pentachloroethane;3;41, Sup 7, 71;1999;
76-03-9;Trichloroacetic acid;2B;63, 84, 106;2014;
76-44-8;Heptachlor;2B;Sup 7, 53, 79;2001;
77-09-8;Phenolphthalein;2B;76;2000;
77-78-1;Dimethyl sulfate;2A;4, Sup 7, 71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
78-79-5;Isoprene;2B;60, 71;1999;
78-87-5;1,2-Dichloropropane;1;41, Sup 7, 71, 110;2016 online;
78-98-8;Methylglyoxal;3;51;1991;
79-00-5;1,1,2-Trichloroethane;3;52, 71;1999;
79-01-6;Trichloroethylene;1;Sup 7, 63, 106;2014;
79-06-1;Acrylamide;2A;60, Sup 7;1994;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-10-7;Acrylic acid;3;19, Sup 7, 71;1999;
79-34-5;1,1,2,2-Tetrachloroethane;2B;20, Sup 7, 71, 106;2014;
79-43-6;Dichloroacetic acid;2B;63, 84, 106;2014;
79-44-7;Dimethylcarbamoyl chloride;2A;12, Sup 7, 71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-46-9;2-Nitropropane;2B;29, Sup 7, 71;1999;
79-94-7;Tetrabromobisphenol A;2A;115;In prep.;
80-08-0;Dapsone;3;24, Sup 7;1987;
80-62-6;Methyl methacrylate;3;Sup 7, 60;1994;
81-07-2;Saccharin and its salts;3;Sup 7, 73;1999;NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
81-15-2;Musk xylene;3;65;1996;
81-49-2;1-Amino-2,4-dibromoanthraquinone;2B;101;2013;
81-88-9;Rhodamine B;3;16, Sup 7;1987;
82-28-0;1-Amino-2-methylanthraquinone;3;27, Sup 7;1987;
82-68-8;Quintozene (Pentachloronitrobenzene);3;5, Sup 7;1987;
83-32-9;Acenaphthene;3;92;2010;
83-63-6;Diacetylaminoazotoluene;3;8, Sup 7;1987;
83-66-9;Musk ambrette;3;65;1996;
83-67-0;Theobromine;3;51;1991;
84-65-1;Anthraquinone;2B;101;2013;
85-01-8;Phenanthrene;3;Sup 7, 92;2010;
85-68-7;Butyl benzyl phthalate;3;Sup 7, 73;1999;
85-83-6;Scarlet Red;3;8, Sup 7;1987;
85-84-7;Yellow AB;3;8, Sup 7;1987;
85-86-9;Sudan III;3;8, Sup 7;1987;
86-30-6;<i>N</i>-Nitrosodiphenylamine;3;27, Sup 7;1987;
86-54-4;Hydralazine;3;24, Sup 7;1987;
86-57-7;1-Nitronaphthalene;3;46;1989;
86-73-7;Fluorene;3;Sup 7, 92;2010;
86-74-8;Carbazole;2B;32, Sup 7, 71, 103;2013;
86-88-4;1-Naphthylthiourea (ANTU);3;30, Sup 7;1987;
87-29-6;Cinnamyl anthranilate;3;Sup 7, 77;2000;
87-62-7;2,6-Dimethylaniline (2,6-Xylidine);2B;57;1993;
87-68-3;Hexachlorobutadiene;3;73;1999;
87-86-5;Pentachlorophenol (see also Polychlorophenols);1;53, 71, 117;In prep.;
88-05-1;2,4,6-Trimethylaniline;3;27, Sup 7;1987;
88-06-2;2,4,6-Trichlorophenol (see also Polychlorophenols);2B;117;In prep.;
88-12-0;<i>N</i>-Vinyl-2-pyrrolidone;3;19, Sup 7, 71;1999;
88-72-2;2-Nitrotoluene;2A;101;2013;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
"88-73-3<br/>
121-73-3<br/>
100-00-5";Chloronitrobenzenes;3;65;1996;
89-82-7;Pulegone;2B;108;2016;
90-04-0;<i>ortho</i>-Anisidine;2B;Sup 7, 73;1999;
90-43-7;<i>ortho</i>-Phenylphenol;3;73;1999;
90-65-3;Penicillic acid;3;10, Sup 7;1987;
90-94-8;Michler’s ketone [4,4´-Bis(dimethylamino)­benzophenone];2B;99;2010;
91-20-3;Naphthalene;2B;82;2002;
91-23-6;2-Nitroanisole;2B;65;1996;
91-59-8;2-Naphthylamine;1;4, Sup 7, 99, 100F;2012;
91-64-5;Coumarin;3;Sup 7, 77;2000;
91-93-0;3,3'-Dimethoxybenzidine-4,4'-diisocyanate;3;39, Sup 7;1987;
91-94-1;3,3'-Dichlorobenzidine;2B;29, Sup 7;1987;
92-67-1;4-Aminobiphenyl;1;1, Sup 7, 99, 100F;2012;
92-87-5;Benzidine;1;29, Sup 7, 99, 100F;2012;
92-93-3;4-Nitrobiphenyl;3;4, Sup 7;1987;
93-15-2;Methyleugenol;2B;101;2013;
94-36-0;Benzoyl peroxide;3;36, Sup 7, 71;1999;
94-58-6;Dihydrosafrole;2B;10, Sup 7;1987;
94-59-7;Safrole;2B;10, Sup 7;1987;
94-75-7;2,4-D (2,4-dichlorophenoxyacetic acid) (See also Chlorophenoxy herbicides);2B;113;In prep.;
95-06-7;Sulfallate;2B;30, Sup 7;1987;
95-50-1;<i>ortho</i>-Dichlorobenzene;3;Sup 7, 73;1999;
95-53-4;<i>orth</i>o-Toluidine;1;Sup 7, 77, 99, 100F;2012;
95-68-1;2,4-Xylidine;3;16, Sup 7;1987;
95-69-2;4-Chloro-<i>ortho</i>-toluidine;2A;77, 99;2010;
95-70-5;2,5-Diaminotoluene;3;16, Sup 7;1987;
95-78-3;2,5-Xylidine;3;16, Sup 7;1987;
95-79-4;5-Chloro-<i>ortho</i>-toluidine;3;77, 99;2010;
95-80-7;2,4-Diaminotoluene;2B;16, Sup 7;1987;
95-83-0;4-Chloro-<i>ortho</i>-phenylenediamine;2B;27, Sup 7;1987;
96-09-3;Styrene-7,8-oxide;2A;Sup 7, 60;1994;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
96-12-8;1,2-Dibromo-3-chloropropane;2B;20, Sup 7, 71;1999;
96-13-9;2,3-Dibromopropan-1-ol;2B;77;2000;
96-18-4;1,2,3-Trichloropropane;2A;63;1995;
96-23-1;1,3-Dichloro-2-propanol;2B;101;2013;
96-24-2;3-Monochloro-1,2-propanediol;2B;101;2013;
96-33-3;Methyl acrylate;3;39, Sup 7, 71;1999;
96-45-7;Ethylenethiourea;3;Sup 7, 79;2001;NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
96-48-0;gamma-Butyrolactone;3;11, Sup 7, 71;1999;
97-53-0;Eugenol;3;36, Sup 7;1987;
97-56-3;<i>ortho</i>-Aminoazotoluene;2B;8, Sup 7;1987;
97-77-8;Disulfiram;3;12, Sup 7;1987;
98-01-1;Furfural;3;63;1995;
98-82-8;Cumene;2B;101;2013;
98-83-9;a-Methylstyrene;2B;101;2013;
"98-87-3<br/>
98-07-7<br/>
100-44-7<br/>
98-88-4";alpha-Chlorinated toluenes (benzal chloride, benzotrichloride, benzyl chloride) and benzoyl chloride (combined exposures);2A;29, Sup 7, 71;1999;
98-95-3;Nitrobenzene;2B;65;1996;
"99-08-1<br/>
99-99-0";Nitrotoluenes;3;65;1996;
99-55-8;5-Nitro-<i>ortho</i>-toluidine;3;48;1990;
99-56-9;1,2-Diamino-4-nitrobenzene;3;16, Sup 7;1987;
99-57-0;2-Amino-4-nitrophenol;3;57;1993;
99-59-2;5-Nitro-<i>ortho</i>-anisidine;3;27, Sup 7;1987;
99-80-9;<i>N</i>-Methyl-<i>N</i>,4-dinitrosoaniline;3;1, Sup 7;1987;
99-97-8;Dimethyl-p-toluidine;2B;115;In prep.;
100-40-3;4-Vinylcyclohexene;2B;Sup 7, 60;1994;
100-41-4;Ethylbenzene;2B;77;2000;
100-42-5;Styrene;2B;60, 82;2002;
100-75-4;<i>N</i>-Nitrosopiperidine;2B;17, Sup 7;1987;
101-14-4;4,4'-Methylenebis(2-chloroaniline) (MOCA);1;Sup 7, 57, 99, 100F;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
101-21-3;Chloropropham;3;12, Sup 7;1987;
101-25-7;Dinitrosopentamethylenetetramine;3;11, Sup 7;1987;
101-61-1;Michler’s base [4,4´-methylenebis(<i>N</i>,<i>N</i>-dimethyl)­benzenamine];2B;27, Sup 7, 99;2010;
101-68-8;4,4'-Methylenediphenyl diisocyanate;3;19, Sup 7, 71;1999;
101-77-9;4,4'-Methylenedianiline;2B;39, Sup 7;1987;
101-80-4;4,4'-Diaminodiphenyl ether;2B;29, Sup 7;1987;
101-90-6;Diglycidyl resorcinol ether;2B;36, Sup 7, 71;1999;
102-50-1;<i>meta</i>-Cresidine;3;27, Sup 7;1987;
102-71-6;Triethanolamine;3;77;2000;
103-03-7;Phenicarbazide;3;12, Sup 7;1987;
103-11-7;2-Ethylhexyl acrylate;3;60;1994;
103-23-1;Di(2-ethylhexyl) adipate;3;Sup 7, 77;2000;
103-33-3;Azobenzene;3;8, Sup 7;1987;
103-90-2;Acetaminophen (see Paracetamol);;;;
103-90-2;Paracetamol (Acetaminophen);3;50, 73;1999;
104-94-9;<i>para</i>-Anisidine;3;27, Sup 7;1987;
105-11-3;<i>para</i>-Benzoquinone dioxime;3;29, Sup 7, 71;1999;
105-55-5;<i>N</i>,<i>N</i>'-Diethylthiourea;3;79;2001;
105-60-2;Caprolactam;4;39, Sup 7, 71;1999;
105-74-8;Lauroyl peroxide;3;36, Sup 7, 71;1999;
106-46-7;<i>para</i>-Dichlorobenzene;2B;Sup 7, 73;1999;
106-47-8;<i>para</i>-Chloroaniline;2B;57;1993;
106-50-3;<i>para</i>-Phenylenediamine;3;16, Sup 7;1987;
106-51-4;<i>para</i>-Quinone;3;15, Sup 7, 71;1999;
106-87-6;4-Vinylcyclohexene diepoxide;2B;Sup 7, 60;1994;
106-88-7;1,2-Epoxybutane;2B;47, 71;1999;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
106-89-8;Epichlorohydrin;2A;11, Sup 7, 71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-93-4;Ethylene dibromide;2A;15, Sup 7, 71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-94-5;1-Bromopropane;2B;115;In prep.;
106-99-0;1,3-Butadiene;1;Sup 7, 54, 71, 97, 100F;2012;
107-02-8;Acrolein;3;63, Sup 7;1995;
107-05-1;Allyl chloride;3;36, Sup 7, 71;1999;
107-06-2;1,2-Dichloroethane;2B;20, Sup 7, 71;1999;
107-13-1;Acrylonitrile;2B;71;1999;
107-14-2;Chloroacetonitrile;3;52, 71;1999;
107-30-2;"Chloromethyl methyl ether (see Bis(chloromethyl)ether; chloromethyl methyl ether)";;;;
108-05-4;Vinyl acetate;2B;Sup 7, 63;1995;
108-10-1;Methyl isobutyl ketone;2B;101;2013;
108-30-5;Succinic anhydride;3;15, Sup 7;1987;
108-45-2;<i>meta</i>-Phenylenediamine;3;16, Sup 7;1987;
108-46-3;Resorcinol;3;15, Sup 7, 71;1999;
108-60-1;Bis(2-chloro-1-methylethyl)ether;3;41, Sup 7, 71;1999;
108-78-1;Melamine;3;Sup 7, 73;1999;NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
108-88-3;Toluene;3;47, 71;1999;
108-94-1;Cyclohexanone;3;47, 71;1999;
108-95-2;Phenol;3;47, 71;1999;
110-00-9;Furan;2B;63;1995;
110-57-6;<i>trans</i>-1,4-Dichlorobutene;3;15, Sup 7, 71;1999;
110-86-1;Pyridine;3;77;2000;
110-91-8;Morpholine;3;47, 71;1999;
111-42-2;Diethanolamine;2B;77, 101;2013;
111-44-4;Bis(2-chloroethyl)ether;3;9, Sup 7, 71;1999;
111-76-2;2-Butoxyethanol;3;88;2006;
115-02-6;Azaserine;2B;10, Sup 7;1987;
115-07-1;Propylene;3;Sup 7, 60;1994;
115-28-6;Chlorendic acid;2B;48;1990;
115-32-2;Dicofol;3;30, Sup 7;1987;
115-96-8;Tris(2-chloroethyl) phosphate;3;48, 71;1999;
116-06-3;Aldicarb;3;53;1991;
116-14-3;Tetrafluoroethylene;2A;19, Sup 7, 71, 110;2016 online;NB: Overall evaluation upgraded to Group 2A on the basis of sufficient evidence in experimental animals with a striking and atypical pattern of tumours
117-10-2;"Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)";2B;50;1990;
117-39-5;Quercetin;3;Sup 7, 73;1999;
117-79-3;2-Aminoanthraquinone;3;27, Sup 7;1987;
117-81-7;Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl) phthalate);;;;
117-81-7;Di(2-ethylhexyl)phthalate;2B;Sup 7, 77, 101;2013;
118-74-1;Hexachlorobenzene;2B;Sup 7, 79;2001;
118-92-3;Anthranilic acid;3;16, Sup 7;1987;
118-96-7;2,4,6-Trinitrotoluene;3;65;1996;
119-34-6;4-Amino-2-nitrophenol;3;16, Sup 7;1987;
119-61-9;Benzophenone;2B;101;2013;
119-90-4;3,3'-Dimethoxybenzidine (<i>ortho</i>-Dianisidine);2B;4, Sup 7;1987;
119-93-7;3,3'-Dimethylbenzidine (<i>ortho</i>-Tolidine);2B;1, Sup 7;1987;
120-12-7;Anthracene;3;92, Sup 7;2010;
120-58-1;Isosafrole;3;10, Sup 7;1987;
120-71-8;<i>para</i>-Cresidine;2B;27, Sup 7;1987;
120-80-9;Catechol;2B;15, Sup 7, 71;1999;
121-14-2;2,4-Dinitrotoluene;2B;65;1996;
121-66-4;2-Amino-5-nitrothiazole;3;31, Sup 7;1987;
121-69-7;<i>N</i>,<i>N</i>-Dimethylaniline;3;57;1993;
121-75-5;Malathion;2A;30, Sup 7, 112;2015 online;
121-88-0;2-Amino-5-nitrophenol;3;57;1993;
122-34-9;Simazine;3;53, 73;1999;
122-42-9;Propham;3;12, Sup 7;1987;
122-60-1;Phenyl glycidyl ether;2B;47, 71;1999;
123-31-9;Hydroquinone;3;15, Sup 7, 71;1999;
123-33-1;Maleic hydrazide;3;4, Sup 7;1987;
123-91-1;1,4-Dioxane;2B;11, Sup 7, 71;1999;
124-48-1;Chlorodibromomethane;3;52, 71;1999;
124-58-3;Methylarsonic acid;2B;100C;2012;
124-58-3;Monomethylarsonic acid (see Methylarsonic acid);2B;100C;2012;
125-33-7;Primidone;2B;108;2016;
126-07-8;Griseofulvin;2B;Sup 7, 79;2001;
126-72-7;Tris(2,3-dibromopropyl) phosphate;2A;20, Sup 7, 71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
126-85-2;Nitrogen mustard <i>N</i>-oxide;2B;9, Sup 7;1987;
126-99-8;Chloroprene;2B;Sup 7, 71;1999;
127-07-1;Hydroxyurea;3;76;2000;
127-18-4;Tetrachloroethylene (Perchloroethylene);2A;Sup 7, 63, 106;2014;
127-69-5;Sulfafurazole (Sulfisoxazole);3;24, Sup 7;1987;
128-37-0;Butylated hydroxytoluene (BHT);3;40, Sup 7;1987;
128-66-5;Vat Yellow 4;3;48;1990;
129-00-0;Pyrene;3;Sup 7, 92;2010;
129-15-7;2-Methyl-1-nitroanthraquinone (uncertain purity);2B;27, Sup 7;1987;
129-17-9;Blue VRS;3;16, Sup 7;1987;
129-20-4;Oxyphenbutazone;3;13, Sup 7;1987;
129-43-1;1-Hydroxyanthraquinone;2B;82;2002;
131-79-3;Yellow OB;3;8, Sup 7;1987;
132-27-4;Sodium <i>ortho</i>-phenylphenate;2B;Sup 7, 73;1999;
132-65-0;Dibenzothiophene;3;103;2013;
133-06-2;Captan;3;30, Sup 7;1987;
134-32-7;1-Naphthylamine;3;4, Sup 7;1987;
135-88-6;<i>N</i>-Phenyl-2-naphthylamine;3;16, Sup 7;1987;
136-40-3;Phenazopyridine hydrochloride;2B;24, Sup 7;1987;
137-17-7;2,4,5-Trimethylaniline;3;27, Sup 7;1987;
137-26-8;Thiram;3;Sup 7, 53;1991;
137-30-4;Ziram;3;Sup 7, 53;1991;
138-59-0;Shikimic acid;3;40, Sup 7;1987;
139-05-9;Cyclamates (sodium cyclamate);3;Sup 7, 73;1999;
139-13-9;Nitrilotriacetic acid and its salts;2B;48, 73;1999;NB: Evaluated as a group
139-65-1;4,4'-Thiodianiline;2B;27, Sup 7;1987;
139-94-6;Nithiazide;3;31, Sup 7;1987;
140-11-4;Benzyl acetate;3;40, Sup 7, 71;1999;
140-56-7;<i>para</i>-Dimethylaminoazobenzenediazo sodium sulfonate;3;8, Sup 7;1987;
140-57-8;Aramite®;2B;5, Sup 7;1987;
140-88-5;Ethyl acrylate;2B;39, Sup 7, 71;1999;
141-32-2;<i>n</i>-Butyl acrylate;3;39, Sup 7, 71;1999;
141-37-7;3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate;3;11, Sup 7, 71;1999;
141-90-2;Thiouracil;2B;Sup 7, 79;2001;
142-83-6;2,4-Hexadienal;2B;101;2013;
143-50-0;Chlordecone (Kepone);2B;20, Sup 7;1987;
143-67-9;Vinblastine sulfate;3;26, Sup 7;1987;
144-34-3;Methyl selenac;3;12, Sup 7;1987;
148-18-5;Sodium diethyldithiocarbamate;3;12, Sup 7;1987;
148-24-3;8-Hydroxyquinoline;3;13, Sup 7;1987;
148-82-3;Melphalan;1;9, Sup 7, 100A;2012;
149-29-1;Patulin;3;40, Sup 7;1987;
149-30-4;2-Mercaptobenzothiazole;2A;115;In prep.;
150-13-0;<i>para</i>-Aminobenzoic acid;3;16, Sup 7;1987;
150-68-5;Monuron;3;Sup 7, 53;1991;
150-69-6;Dulcin;3;12, Sup 7;1987;
151-56-4;Aziridine;2B;9, Sup 7, 71;1999;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
154-93-8;Bischloroethyl nitrosourea (BCNU);2A;26, Sup 7;1987;
156-10-5;<i>para</i>-Nitrosodiphenylamine;3;27, Sup 7;1987;
156-51-4;Phenelzine sulfate;3;24, Sup 7;1987;
189-55-9;Dibenzo[<i>a</i>,<i>i</i>]pyrene;2B;92;2010;
189-64-0;Dibenzo[<i>a</i>,<i>h</i>]pyrene;2B;Sup 7, 92;2010;
191-07-1;Coronene;3;32, Sup 7, 92;1987;
191-24-2;Benzo[<i>ghi</i>]perylene;3;92, Sup 7;2010;
191-26-4;Anthanthrene;3;92, Sup 7;2010;
191-30-0;Dibenzo[<i>a</i>,<i>l</i>]pyrene;2A;Sup 7, 92;2010;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
192-47-2;Dibenzo[<i>h</i>,<i>rst</i>]pentaphene;3;Sup 7, 92;2010;
192-51-8;Dibenzo[<i>e</i>,<i>l</i>]pyrene;3;92;2010;
192-65-4;Dibenzo[<i>a</i>,<i>e</i>]pyrene;3;Sup 7, 92;2010;
192-97-2;Benzo[<i>e</i>]pyrene;3;92, Sup 7;2010;
193-09-9;Naphtho[2,3-<i>e</i>]pyrene;3;92;2010;
193-39-5;Indeno[1,2,3-<i>cd</i>]pyrene;2B;Sup 7, 92;2010;
194-59-2;7H-Dibenzo[<i>c</i>,<i>g</i>]carbazole;2B;32, Sup 7, 103;2013;
195-19-7;Benzo[<i>c</i>]phenanthrene;2B;92, Sup 7;2010;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
196-78-1;Benzo[<i>g</i>]chrysene;3;92;2010;
198-55-0;Perylene;3;Sup 7, 92;2010;
202-33-5;Benz[<i>j</i>]aceanthrylene;2B;92;2010;NB: Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data
202-94-8;11H-Benz[<i>bc</i>]aceanthrylene;3;92;2010;
202-98-2;4H-Cyclopenta[<i>def</i>]chrysene;3;92;2010;
203-12-3;Benzo[<i>ghi</i>]fluoranthene;3;92, Sup 7;2010;
203-20-3;Naphtho[2,1-<i>a</i>]fluoranthene;3;92;2010;
203-33-8;Benzo[<i>a</i>]fluoranthene;3;92, Sup 7;2010;
205-12-9;Benzo[<i>c</i>]fluorene;3;92, Sup 7;2010;
205-82-3;Benzo[<i>j</i>]fluoranthene;2B;92;2010;
205-99-2;Benzo[<i>b</i>]fluoranthene;2B;92;2010;
206-44-0;Fluoranthene;3;Sup 7, 92;2010;
207-08-9;Benzo[<i>k</i>]fluoranthene;2B;92;2010;
207-83-0;13H-Dibenzo[<i>a</i>,<i>g</i>]fluorene;3;92;2010;
211-91-6;Benz[<i>l</i>]aceanthrylene;3;92;2010;
213-46-7;Picene;3;92;2010;
214-17-5;Benzo[<i>b</i>]chrysene;3;92;2010;
215-58-7;Dibenz[<i>a</i>,<i>c</i>]anthracene;3;Sup 7, 92;2010;
217-59-4;Triphenylene;3;Sup 7, 92;2010;
218-01-9;Chrysene;2B;92;2010;
224-41-9;Dibenz[<i>a</i>,<i>j</i>]anthracene;3;Sup 7, 92;2010;
224-42-0;Dibenz[<i>a</i>,<i>j</i>]acridine;2A;32, Sup 7, 103;2013;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
224-53-3;Dibenz[<i>c</i>,<i>h</i>]acridine;2B;103;2013;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
225-11-6;Benz[<i>a</i>]acridine;3;32, Sup 7, 103;2013;
225-51-4;Benz[<i>c</i>]acridine;3;32, Sup 7, 103;2013;
226-36-8;Dibenz[<i>a</i>,<i>h</i>]acridine;2B;32, Sup 7, 103;2013;
238-84-6;Benzo[<i>a</i>]fluorene;3;92, Sup 7;2010;
239-35-0;Benzo[<i>b</i>]naphtho[2,1-d]thiophene;3;103;2013;
243-17-4;Benzo[<i>b</i>]fluorene;3;92, Sup 7;2010;
262-12-4;Dibenzo-<i>para</i>-dioxin;3;69;1997;
271-89-6;Benzofuran;2B;63;1995;
298-00-0;Methyl parathion;3;30, Sup 7;1987;
298-81-7;Methoxsalen (8-methoxypsoralen) plus ultraviolet A radiation;1;24, Sup 7, 100A;2012;
299-75-2;Treosulfan;1;26, Sup 7, 100A;2012;
302-01-2;Hydrazine;2A;4, Sup 7, 71, 115;In prep.;
302-17-0;Chloral hydrate;2A;63, 84, 106;2014;
303-34-4;Lasiocarpine;2B;10, Sup 7;1987;
303-47-9;Ochratoxin A;2B;Sup 7, 56;1993;
305-03-3;Chlorambucil;1;26, Sup 7, 100A;2012;
309-00-2;Aldrin (see Dieldrin, and aldrin metabolized to dieldrin);;;;
313-67-7;Aristolochic acid;1;82, 100A;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
313-67-7;Aristolochic acid, plants containing;1;82, 100A;2012;
314-13-6;Evans blue;3;8, Sup 7;1987;
315-18-4;Zectran;3;12, Sup 7;1987;
315-22-0;Monocrotaline;2B;10, Sup 7;1987;
320-67-2;Azacitidine;2A;50;1990;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
331-39-5;Caffeic acid;2B;56;1993;
333-41-5;Diazinon;2A;112;2015 online;NB: Overall evaluation upgraded to Group 2A based on mechanistic evidence
334-88-3;Diazomethane;3;7, Sup 7;1987;
335-67-1;Perfluorooctanoic acid (PFOA);2B;110;2016;
366-70-1;Procarbazine hydrochloride;2A;26, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
396-01-0;Triamterene;2B;108;2016;
420-12-2;Ethylene sulfide;3;11, Sup 7;1987;
439-14-5;Diazepam;3;Sup 7, 66;1996;
443-48-1;Metronidazole;2B;13, Sup 7;1987;
446-86-6;Azathioprine;1;26, Sup 7, 100A;2012;
480-54-6;Retrorsine;3;10, Sup 7;1987;
480-81-9;Seneciphylline;3;10, Sup 7;1987;
484-20-8;5-Methoxypsoralen;2A;40, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
492-17-1;2,4'-Diphenyldiamine;3;16, Sup 7;1987;
492-80-8;Auramine;2B;1, Sup 7, 99, 100F;2012;
493-52-7;Methyl red;3;8, Sup 7;1987;
494-03-1;Chlornaphazine;1;4, Sup 7, 100A;2012;
494-03-1;<i>N</i>,<i>N</i>-Bis(2-chloroethyl)-2-naphthylamine (see Chlornaphazine);;;;
494-38-2;Acridine orange;3;16, Sup 7;1987;
501-30-4;Kojic acid;3;79;2001;
505-60-2;Mustard gas (see Sulfur mustard);;;;
505-60-2;Sulfur mustard;1;9, Sup 7, 100F;2012;
509-14-8;Tetranitromethane;2B;65;1996;
510-15-6;Chlorobenzilate;3;30, Sup 7;1987;
513-37-1;1-Chloro-2-methylpropene;2B;63;1995;
518-75-2;Citrinin;3;40, Sup 7;1987;
520-18-3;Kaempferol;3;31, Sup 7;1987;
523-44-4;CI Acid Orange 20;3;8, Sup 7;1987;
523-44-4;Orange I (see CI Acid Orange 20);;;;
523-50-2;Angelicin plus ultraviolet A radiation;3;40, Sup 7;1987;
531-76-0;Merphalan;2B;9, Sup 7;1987;
531-82-8;<i>N</i>-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide;2B;7, Sup 7;1987;
532-82-1;Chrysoidine;3;8, Sup 7;1987;
536-33-4;Ethionamide;3;13, Sup 7;1987;
540-73-8;1,2-Dimethylhydrazine;2A;4, Sup 7,  71;1999;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
541-73-1;<i>meta</i>-Dichlorobenzene;3;73;1999;
542-75-6;1,3-Dichloropropene (technical-grade);2B;41, Sup 7, 71;1999;
542-78-9;Malonaldehyde;3;36, Sup 7, 71;1999;
"542-88-1<br/>
107-30-2";"Bis(chloromethyl)ether; chloromethyl methyl ether (technical-grade)";1;4, Sup 7, 100F;2012;
545-06-2;Trichloroacetonitrile;3;52, 71;1999;
545-55-1;Tris(1-aziridinyl)phosphine oxide;3;9, Sup 7;1987;
551-74-6;Mannomustine dihydrochloride;3;9, Sup 7;1987;
555-84-0;1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone;2B;7, Sup 7;1987;
556-52-5;Glycidol;2A;77;2000;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
562-10-7;Doxylamine succinate;3;79;2001;
563-41-7;Semicarbazide hydrochloride;3;12, Sup 7;1987;
563-47-3;3-Chloro-2-methylpropene, technical grade;2B;63, 115;In prep.;
569-61-9;CI Basic Red 9;2B;57, 99;2010;
581-89-5;2-Nitronaphthalene;3;46;1989;
592-62-1;Methylazoxymethanol acetate;2B;10, Sup 7;1987;
593-60-2;Vinyl bromide;2A;39, Sup 7, 71, 97;2008;"NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data;
(2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride"
593-70-4;Chlorofluoromethane;3;41, Sup 7, 71;1999;
598-55-0;Methyl carbamate;3;12, Sup 7;1987;
599-79-1;Sulfasalazine;2B;108;2016;
602-60-8;9-Nitroanthracene;3;33, Sup 7;1987;
602-87-9;5-Nitroacenaphthene;2B;16, Sup 7;1987;
604-75-1;Oxazepam;2B;Sup 7, 66;1996;
606-20-2;2,6-Dinitrotoluene;2B;65;1996;
607-57-8;2-Nitrofluorene;2B;46, 105;2013;
609-20-1;2,6-Dichloro-<i>para</i>-phenylenediamine;3;39, Sup 7;1987;
613-35-4;<i>N</i>,<i>N</i>'-Diacetylbenzidine;2B;16, Sup 7;1987;
615-05-4;2,4-Diaminoanisole;2B;Sup 7, 79;2001;
615-53-2;<i>N</i>-Methyl-<i>N</i>-nitrosourethane;2B;4, Sup 7;1987;
618-85-9;3,5-Dinitrotoluene;3;65;1996;
621-64-7;<i>N</i>-Nitrosodi-<i>n</i>-propylamine;2B;17, Sup 7;1987;
627-12-3;<i>n</i>-Propyl carbamate;3;12, Sup 7;1987;
630-20-6;1,1,1,2-Tetrachloroethane;2B;41, Sup 7, 71, 106;2014;
631-64-1;Dibromoacetic acid;2B;101;2013;
632-99-5;Magenta;2B;Sup 7, 57, 99, 100F;2012;
637-07-0;Clofibrate;3;Sup 7, 66;1996;
641-48-5;Dihydroaceanthrylene;3;92;2010;
680-31-9;Hexamethylphosphoramide;2B;15, Sup 7, 71;1999;
684-93-5;<i>N</i>-Methyl-<i>N</i>-nitrosourea;2A;17, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
693-98-1;2-Methylimidazole;2B;101;2013;
712-68-5;2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole;2B;7, Sup 7;1987;
723-46-6;Sulfamethoxazole;3;Sup 7, 79;2001;
759-73-9;<i>N</i>-Ethyl-<i>N</i>-nitrosourea;2A;17, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
765-34-4;Glycidaldehyde;2B;11, Sup 7, 71;1999;
789-07-1;2-Nitropyrene;3;46;1989;
794-93-4;Dihydroxymethylfuratrizine (see also Panfuran S);3;24, Sup 7;1987;
794-93-4;Panfuran S (containing dihydroxymethylfuratrizine);2B;24, Sup 7;1987;
800-24-8;Aziridyl benzoquinone;3;9, Sup 7;1987;
804-36-4;Nitrovin;3;31, Sup 7;1987;
817-09-4;Trichlormethine (Trimustine hydrochloride);2B;Sup 7, 50;1990;
822-36-6;4-Methylimidazole;2B;101;2013;
828-00-2;Dimethoxane;3;15, Sup 7;1987;
832-69-9;1-Methylphenanthrene;3;Sup 7, 92;2010;
838-88-0;4,4'-Methylene bis(2-methylaniline);2B;4, Sup 7;1987;
842-07-9;Sudan I;3;8, Sup 7;1987;
846-50-4;Temazepam;3;66;1996;
868-85-9;Dimethyl hydrogen phosphite;3;48, 71;1999;
892-21-7;3-Nitrofluoranthene;3;33, Sup 7;1987;
915-67-3;Amaranth;3;8, Sup 7;1987;
924-16-3;<i>N</i>-Nitrosodi-<i>n</i>-butylamine;2B;17, Sup 7;1987;
930-55-2;<i>N</i>-Nitrosopyrrolidine;2B;17, Sup 7;1987;
989-38-8;Rhodamine 6G;3;16, Sup 7;1987;
1071-83-6;Glyphosate;2A;112;2015 online;
1072-52-2;2-(1-Aziridinyl)ethanol;3;9, Sup 7;1987;
1116-54-7;<i>N</i>-Nitrosodiethanolamine;2B;17, Sup 7, 77;2000;
1120-71-4;1,3-Propane sultone;2A;4, Sup 7, 71, 110;2016;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
1143-38-0;Dithranol;3;"13; Sup 7";1987;
1163-19-5;Decabromodiphenyl oxide;3;48, 71;1999;
1303-00-0;Gallium arsenide (see Arsenic and inorganic arsenic compounds);;86, 100C;2012;
1309-37-1;Ferric oxide;3;1, Sup 7;1987;
1309-64-4;Antimony trioxide;2B;47;1989;
1314-62-1;Vanadium pentoxide;2B;86;2006;
1317-60-8;Haematite;3;1, Sup 7;1987;
1318-02-1;Zeolites other than erionite (clinoptilolite, phillipsite,mordenite, non-fibrous Japanese zeolite, synthetic zeolites);3;68;1997;
1330-20-7;Xylenes;3;47, 71;1999;
"1332-21-4<br/>
77536-67-5*<br/>
12172-73-5<br/>
77536-66-4*<br/>
12001-29-5<br/>
12001-28-4<br/>
77536-68-6*";Asbestos (all forms, including actinolite, amosite, anthophyllite, chrysotile, crocidolite, tremolite);1;14, Sup 7, 100C;2012;"NB: Mineral substances (e.g. talc or vermiculite) that contain asbestos should also be regarded as carcinogenic to humans<br/>
*The presence of an asterisk indicates that the registration is for a substance which CAS does not treat in its regular CA index"
1333-86-4;Carbon black;2B;Sup 7, 65, 93;2010;
1336-36-3;Polychlorinated biphenyls;1;18, Sup 7, 107;2016;
1338-16-5;Iron sorbitol-citric acid complex;3;2, Sup 7;1987;
1345-04-6;Antimony trisulfide;3;47;1989;
1401-55-4;Tannic acid and tannins;3;10, Sup 7;1987;
1402-68-2;Aflatoxins;1;56, 82, 100F, Sup 7;2012;
1464-53-5;1,2:3,4-Diepoxybutane (see <i>Monographs</i> on 1,3-Butadiene);;11, Sup 7;1987;
1582-09-8;Trifluralin;3;53;1991;
1615-80-1;1,2-Diethylhydrazine;2B;4, Sup 7, 71;1999;
1634-04-4;Methyl <i>tert</i>-butyl ether;3;73;1999;
1675-54-3;Bisphenol A diglycidyl ether (Araldite);3;47, 71;1999;
1689-82-3;4-Hydroxyazobenzene;3;8, Sup 7;1987;
1694-09-3;Benzyl violet 4B;2B;16, Sup 7;1987;
1705-85-7;6-Methylchrysene;3;Sup 7, 92;2010;
1706-01-0;3-Methylfluoranthene;3;Sup 7, 92;2010;
1746-01-6;2,3,7,8-Tetrachlorodibenzo-<i>para</i>-dioxin;1;Sup 7, 69, 100F;2012;
1836-75-5;Nitrofen (technical-grade);2B;30, Sup 7;1987;
1897-45-6;Chlorothalonil;2B;Sup 7, 73;1999;
1912-24-9;Atrazine;3;53, 73;1999;NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
01/02/1918;Picloram;3;53;1991;
1936-15-8;CI Orange G;3;8, Sup 7;1987;
1936-15-8;Orange G (see CI Orange G);;;;
1937-37-7;CI Direct Black 38 (see Benzidine, dyes metabolized to);;;;
1954-28-5;Triethylene glycol diglycidyl ether;3;11, Sup 7, 71;1999;
2068-78-2;Vincristine sulfate;3;26, Sup 7;1987;
2164-17-2;Fluometuron;3;30, Sup 7;1987;
2168-68-5;Bis(1-aziridinyl)morpholinophosphine sulfide;3;9, Sup 7;1987;
2243-62-1;1,5-Naphthalenediamine;3;27, Sup 7;1987;
2303-16-4;Diallate;3;30, Sup 7;1987;
2318-18-5;Senkirkine;3;31, Sup 7;1987;
2353-45-9;Fast Green FCF;3;16, Sup 7;1987;
2385-85-5;Mirex;2B;20, Sup 7;1987;
2386-90-5;Bis(2,3-epoxycyclopentyl)ether ;3;47, 71;1999;
01/06/2425;Captafol;2A;53;1991;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
2425-85-6;CI Pigment Red 3;3;57;1993;
2429-74-5;CI Direct Blue 15;2B;57;1993;
2432-99-7;11-Aminoundecanoic acid;3;39, Sup 7;1987;
2475-45-8;Disperse Blue 1;2B;48;1990;
2602-46-2;CI Direct Blue 6 (see Benzidine, dyes metabolized to);;;;
2646-17-5;Oil Orange SS;2B;8, Sup 7;1987;
2757-90-6;Agaritine;3;31, Sup 7;1987;
2783-94-0;Sunset Yellow FCF;3;8, Sup 7;1987;
2784-94-3;HC Blue No. 1;2B;57;1993;
2832-40-8;Disperse Yellow 3;3;48;1990;
2835-39-4;Allyl isovalerate;3;36, Sup 7, 71;1999;
04/01/2871;HC Red No. 3;3;57;1993;
2955-38-6;Prazepam;3;66;1996;
06/10/2973;Diisopropyl sulfate;2B;54, 71;1999;
3018-12-0;Dichloroacetonitrile;3;52, 71;1999;
3068-88-0;beta-Butyrolactone;2B;11, Sup 7, 71;1999;
3118-97-6;Sudan II;3;8, Sup 7;1987;
3173-72-6;1,5-Naphthalene diisocyanate;3;19, Sup 7, 71;1999;
3252-43-5;Dibromoacetonitrile;2B;52, 71, 101;2013;
3296-90-0;2,2-Bis(bromomethyl)propane-1,3-diol;2B;77;2000;
3351-28-8;1-Methylchrysene;3;Sup 7, 92;2010;
3351-30-2;4-Methylchrysene;3;Sup 7, 92;2010;
3351-31-3;3-Methylchrysene;3;Sup 7, 92;2010;
3351-32-4;2-Methylchrysene;3;Sup 7, 92;2010;
08/09/3564;Ponceau 3R;2B;8, Sup 7;1987;
3567-69-9;Carmoisine;3;8, Sup 7;1987;
3570-75-0;2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole;2B;7, Sup 7;1987;
3688-53-7;AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide];2B;31, Sup 7;1987;
3697-24-3;5-Methylchrysene;2B;Sup 7, 92;2010;
3761-53-3;Ponceau MX;2B;8, Sup 7;1987;
3771-19-5;Nafenopin;2B;24, Sup 7;1987;
3778-73-2;Isophosphamide;3;26, Sup 7;1987;
3795-88-8;5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)­amino]-2-oxazolidinone;2B;7, Sup 7;1987;
3844-45-9;Brilliant Blue FCF, disodium salt;3;16, Sup 7;1987;
3902-71-4;4,5',8-Trimethylpsoralen;3;40, Sup 7;1987;
4063-41-6;4,5'-Dimethylangelicin plus ultraviolet A radiation;3;Sup 7;1987;
4170-30-3;Crotonaldehyde;3;63;1995;
04/03/4342;Dacarbazine;2B;26, Sup 7;1987;
4548-53-2;Ponceau SX;3;8, Sup 7;1987;
4549-40-0;<i>N</i>-Nitrosomethylvinylamine;2B;17, Sup 7;1987;
4657-93-6;5-Aminoacenaphthene;3;16, Sup 7;1987;
4680-78-8;Guinea Green B;3;16, Sup 7;1987;
5131-60-2;4-Chloro-<i>meta</i>-phenylenediamine;3;27, Sup 7;1987;
5141-20-8;Light Green SF;3;16, Sup 7;1987;
01/02/5160;D & C Red No. 9;3;Sup 7, 57;1993;
5307-14-2;1,4-Diamino-2-nitrobenzene;3;Sup 7, 57;1993;
5385-75-1;Dibenzo[<i>a</i>,<i>e</i>]fluoranthene;3;Sup 7, 92;2010;
5431-33-4;Glycidyl oleate;3;11, Sup 7;1987;
5456-28-0;Ethyl selenac;3;12, Sup 7;1987;
5522-43-0;1-Nitropyrene;2A;Sup 7, 46, 105;2014;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
5589-96-8;Bromochloroacetic acid;2B;101;2013;
5989-27-5;<i>d</i>-Limonene;3;56, 73;1999;NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
6164-98-3;Chlordimeform;3;30, Sup 7;1987;
6358-53-8;Citrus Red No. 2;2B;8, Sup 7;1987;
6368-72-5;Sudan Red 7B;3;8, Sup 7;1987;
6373-74-6;CI Acid Orange 3;3;57;1993;
6416-57-5;Sudan Brown RR;3;8, Sup 7;1987;
6459-94-5;CI Acid Red 114;2B;57;1993;
6795-23-9;Aflatoxin M1;2B;56;1993;
6870-67-3;Jacobine;3;10, Sup 7;1987;
7099-43-6;5,6-Cyclopenteno-1,2-benzanthracene;3;92;2010;
7220-79-3;Methylene blue;3;108;2016;
7439-92-1;Lead;2B;23, Sup 7;1987;
7439-97-6;Mercury and inorganic mercury compounds;3;58;1993;
7440-02-0;Nickel, metallic and alloys;2B;Sup 7, 49;1990;
05/07/7440;Plutonium;1;78, 100D;2012;
7440-29-1;Thorium-232 and its decay products;1;78, 100D;2012;
7440-38-2;Arsenic and inorganic arsenic compounds;1;23, Sup 7, 100C;2012;
7440-41-7;Beryllium and beryllium compounds;1;Sup 7, 58, 100C;2012;
7440-43-9;Cadmium and cadmium compounds;1;58, 100C;2012;
7440-47-3;Chromium, metallic;3;Sup 7, 49;1990;
7440-48-4;Cobalt and cobalt compounds;2B;52;1991;NB: Evaluated as a group
7440-48-4;Cobalt metal without tungsten carbide;2B;86;2006;
"7440-48-4<br/>
12070-12-1";Cobalt metal with tungsten carbide;2A;86;2006;
05/09/7446;Sulfur dioxide;3;54;1992;
7460-84-6;Glycidyl stearate;3;11, Sup 7;1987;
7481-89-2;Zalcitabine;2B;76;2000;
08/02/7496;6-Nitrochrysene;2A;Sup 7, 46, 105;2014;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
7519-36-0;<i>N</i>-Nitrosoproline;3;17, Sup 7;1987;
7572-29-4;Dichloroacetylene;3;39, Sup 7, 71;1999;
7631-86-9;Silica, amorphous;3;Sup 7, 68;1997;
7647-01-0;Hydrochloric acid;3;54;1992;
7664-93-9;Strong-inorganic-acid mists containing sulfuric acid (see Acid mists);;;;
7722-84-1;Hydrogen peroxide;3;36, Sup 7, 71;1999;
02/01/7758;Potassium bromate;2B;Sup 7, 73;1999;
7758-19-2;Sodium chlorite;3;52;1991;
7782-49-2;Selenium and selenium compounds;3;9, Sup 7;1987;
8001-35-2;Toxaphene (Polychlorinated camphenes);2B;Sup 7, 79;2001;
8001-50-1;Terpene polychlorinates (Strobane®);3;5, Sup 7;1987;
8001-58-9;Creosotes;2A;Sup 7, 92;2010;
09/05/8002;Crude oil;3;45;1989;
8007-45-2;Coal tars (see Coal-tar distillation);;35, Sup 7;1987;
8007-45-2;Coal-tar distillation;1;92, 100F;2012;
03/07/8018;Acriflavinium chloride;3;13, Sup 7;1987;
8047-67-4;Saccharated iron oxide;3;2, Sup 7;1987;
8052-42-4;"Bitumens, extracts of steam-refined and air-refined; steam-refined, cracking-residue and air-refined bitumens (see Bitumens, occupational exposures)";;35, Sup 7;1987;
"8052-42-4<br/>
64741-56-6";Bitumens, occupational exposure to straight-run bitumens and their emissions during road paving;2B;103;2013;
01/07/9000;Carrageenan, native;3;31, Sup 7;1987;
9000-38-8;Kava extract;2B;108;2016;
9002-84-0;Polytetrafluoroethylene;3;19, Sup 7;1987;
9002-86-2;Polyvinyl chloride;3;19, Sup 7;1987;
9002-88-4;Polyethylene;3;19, Sup 7;1987;
9002-89-5;Polyvinyl alcohol;3;19, Sup 7;1987;
04/01/9003;Polyacrylic acid;3;19, Sup 7;1987;
9003-07-0;Polypropylene;3;19, Sup 7;1987;
9003-20-7;Polyvinyl acetate;3;19, Sup 7;1987;
9003-22-9;Vinyl chloride-vinyl acetate copolymers;3;19, Sup 7;1987;
9003-39-8;Polyvinyl pyrrolidone;3;19, Sup 7, 71;1987;
9003-53-6;Polystyrene;3;19, Sup 7;1987;
9003-54-7;Styrene-acrylonitrile copolymers;3;19, Sup .7;1987;
9003-55-8;Styrene-butadiene copolymers;3;19, Sup 7;1987;
9004-51-7;Iron-dextrin complex;3;2, Sup 7;1987;
9004-66-4;Iron-dextran complex;2B;2, Sup 7;1987;
9009-54-5;Polyurethane foams;3;19, Sup 7;1987;
9010-98-4;Polychloroprene;3;19, Sup 7;1987;
07/06/9011;Vinylidene chloride-vinyl chloride copolymers;3;19, Sup 7;1987;
9011-14-7;Polymethyl methacrylate;3;19, Sup 7;1987;
9016-87-9;Polymethylene polyphenyl isocyanate;3;19, Sup 7;1987;
10026-24-1;Cobalt sulfate and other soluble cobalt(II) salts;2B;86;2006;
10043-66-0;Iodine-131 (see Radioiodines);;;;
10043-92-2;Radon-222 and its decay products;1;43, 78, 100D;2012;
10048-13-2;Sterigmatocystin;2B;10, Sup 7;1987;
10048-32-5;Parasorbic acid;3;10, Sup 7;1987;
10098-97-2;Strontium-90 (see Fission products);;;;
10380-28-6;Copper 8-hydroxyquinoline;3;15, Sup 7;1987;
10540-29-1;Tamoxifen;1;66, 100A;2012;NB: There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients
10595-95-6;<i>N</i>-Nitrosomethylethylamine;2B;17, Sup 7;1987;
10599-90-3;Chloramine;3;84;2004;
11056-06-7;Bleomycins;2B;26, Sup 7;1987;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
12001-79-5;Vitamin K substances;3;76;2000;
"12070-12-1<br/>
7440-48-4";Tungsten carbide with cobalt metal (see Cobalt metal with tungsten carbide);;;;
12122-67-7;Zineb;3;12, Sup 7;1987;
12174-11-7;Attapulgite (see Palygorskite);;;;
12174-11-7;Palygorskite (Attapulgite) (long fibres, > 5 micrometres);2B;68;1997;
12174-11-7;Palygorskite (Attapulgite)(short fibres, < 5 micrometres);3;68;1997;
12192-57-3;Aurothioglucose;3;13, Sup 7;1987;
12427-38-2;Maneb;3;12, Sup 7;1987;
12663-46-6;Cyclochlorotine;3;10, Sup 7;1987;
13010-47-4;1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU);2A;26, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
13045-94-8;Medphalan;3;9, Sup 7;1987;
13233-32-4;Radium-224 and its decay products;1;78, 100D;2012;
13256-22-9;<i>N</i>-Nitrososarcosine;2B;17, Sup 7;1987;
13292-46-1;Rifampicin;3;24, Sup 7;1987;
13463-67-7;Titanium dioxide;2B;47, 93;2010;
13483-18-6;1,2-Bis(chloromethoxy)ethane;3;"15; Sup 7, 71";1999;
13909-09-6;1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) (see Semustine);;;;
13909-09-6;Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, Methyl-CCNU];1;Sup 7, 100A;2012;
13982-63-3;Radium-226 and its decay products;1;78, 100D;2012;
13983-17-0;Wollastonite;3;Sup 7, 68;1997;
14047-09-7;3,3?,4,4?-Tetrachloroazobenzene;2A;117;In prep.;NB: Overall evaluation upgraded to Group 2A
14484-64-1;Ferbam;3;12, Sup 7;1987;
14596-37-3;Phosphorus-32, as phosphate;1;78, 100D;2012;
14807-96-6;Talc containing asbestiform fibres (see Asbestos);;42, Sup 7;1987;
14807-96-6;Talc not containing asbestos or asbestiform fibres;3;42, Sup 7, 93;2010;
14807-96-6;Talc-based body powder (perineal use of);2B;93;2010;
14808-60-7;Silica dust, crystalline, in the form of quartz or cristobalite;1;Sup 7, 68, 100C;2012;
14901-08-7;Cycasin;2B;10, Sup 7;1987;
15086-94-9;Eosin;3;15, Sup 7;1987;
15262-20-1;Radium-228 and its decay products;1;78, 100D;2012;
15501-74-3;Sepiolite;3;Sup 7, 68;1997;
15503-86-3;Isatidine;3;10, Sup 7;1987;
15663-27-1;Cisplatin;2A;26, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
15721-02-5;2,2',5,5'-Tetrachlorobenzidine;3;27, Sup 7;1987;
16065-83-1;Chromium (III) compounds;3;49;1990;
16071-86-6;CI Direct Brown 95 (see Benzidine, dyes metabolized to);;;;
"16543-55-8<br/>
64091-91-4";<i>N</i>'-Nitrosonornicotine (NNN) and 4-(<i>N</i>-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK);1;Sup 7, 89, 100E;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
16568-02-8;Gyromitrin;3;31, Sup 7;1987;
16984-48-8;Fluorides (inorganic, used in drinking-water);3;27, Sup 7;1987;
17117-34-9;3-Nitrobenzanthrone;2B;105;2014;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
18540-29-9;Chromium (VI) compounds;1;Sup 7, 49, 100C;2012;
18883-66-4;Streptozotocin;2B;17, Sup 7;1987;
20073-24-9;3-Carbethoxypsoralen;3;40, Sup 7;1987;
20268-51-3;7-Nitrobenz[<i>a</i>]anthracene;3;46;1989;
20589-63-3;3-Nitroperylene;3;46;1989;
20830-75-5;Digoxin;2B;108;2016;
20830-81-3;Daunomycin;2B;10, Sup 7;1987;
20941-65-5;Ethyl tellurac;3;12, Sup 7;1987;
21884-44-6;Luteoskyrin;3;10, Sup 7;1987;
22248-79-9;Tetrachlorvinphos;2B;30, Sup 7, 112;2017 online;
22349-59-3;1,4-Dimethylphenanthrene;3;Sup 7, 92;2010;
22398-80-7;Indium phosphide;2A;86;2006;NB: Overall evaluation upgraded to Group 2A
22506-53-2;3,9-Dinitrofluoranthene;2B;46, 65, 105;2013;
22571-95-5;Symphytine;3;31, Sup 7;1987;
22966-79-6;Oestradiol mustard;3;9, Sup 7;1987;
22975-76-4;4,4'-Dimethylangelicin plus ultraviolet A radiation;3;Sup 7;1987;
23214-92-8;Adriamycin;2A;10, Sup 7;1987;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
23246-96-0;Riddelliine;2B;10, Sup 7, 82;2002;
23255-93-8;Hycanthone mesylate;3;13, Sup 7;1987;
23537-16-8;Rugulosin;3;40, Sup 7;1987;
23746-34-1;Potassium bis(2-hydroxyethyl)dithiocarbamate;3;12, Sup 7;1987;
24560-98-3;<i>cis</i>-9,10-Epoxystearic acid;3;11, Sup 7, 71;1999;
24938-64-5;<i>para</i>-Aramid fibrils;3;68;1997;
25013-15-4;Vinyl toluene;3;60;1994;
25013-16-5;Butylated hydroxyanisole (BHA);2B;40, Sup 7;1987;
25038-54-4;Nylon 6;3;19, Sup 7;1987;
25732-74-5;Acepyrene (3,4-dihydrocyclopenta[<i>cd</i>]pyrene);3;92;2010;
25812-30-0;Gemfibrozil;3;66;1996;
25962-77-0;<i>trans</i>-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)-vinyl]-1,3,4-oxadiazole;2B;7, Sup 7;1987;
26148-68-5;A-alpha-C (2-Amino-9<i>H</i>-pyrido[2,3-<i>b</i>]indole);2B;40, Sup 7;1987;
26308-28-1;Ripazepam;3;66;1996;
26471-62-5;Toluene diisocyanates;2B;39, Sup 7, 71;1999;
26782-43-4;Hydroxysenkirkine;3;10, Sup 7;1987;
27208-37-3;Cyclopenta[<i>cd</i>]pyrene;2A;Sup 7, 92;2010;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
28434-86-8;3,3'-Dichloro-4,4'-diaminodiphenyl ether;2B;16, Sup 7;1987;
29069-24-7;Prednimustine;3;50;1990;
29291-35-8;<i>N</i>-Nitrosofolic acid;3;17, Sup 7;1987;
29767-20-2;Teniposide;2A;76;2000;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
29975-16-4;Estazolam;3;66;1996;
30310-80-6;<i>N</i>-Nitrosohydroxyproline;3;17, Sup 7;1987;
30516-87-1;Zidovudine (AZT);2B;76;2000;
33229-34-4;HC Blue No. 2;3;57;1993;
33419-42-0;Etoposide;1;76, 100A;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
"33419-42-0<br/>
15663-27-1<br/>
11056-06-7";Etoposide in combination with cisplatin and bleomycin;1;76, 100A;2012;
33543-31-6;2-Methylfluoranthene;3;Sup 7, 92;2010;
37319-17-8;Pentosan polysulfate sodium;2B;108;2016;
37620-20-5;<i>N</i>'-Nitrosoanabasine (NAB);3;37, Sup 7, 89;2007;
38571-73-2;1,2,3-Tris(chloromethoxy)propane;3;15, Sup 7, 71;1999;
40762-15-0;Doxefazepam;3;66;1996;
42397-64-8;1,6-Dinitropyrene;2B;46, 105;2013;
42397-65-9;1,8-Dinitropyrene;2B;Sup 7, 46, 105;2013;
51264-14-3;Amsacrine;2B;76;2000;
51481-61-9;Cimetidine;3;50;1990;
51630-58-1;Fenvalerate;3;53;1991;
52645-53-1;Permethrin;3;53;1991;
52918-63-5;Deltamethrin;3;53;1991;
53973-98-1;Carrageenan, degraded (Poligeenan);2B;31, Sup 7;1987;
53973-98-1;Poligeenan (see Carrageenan, degraded);;;;
54749-90-5;Chlorozotocin;2A;50;1990;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
55557-01-2;<i>N</i>-Nitrosoguvacine;3;Sup 7, 85;2004;
55557-02-3;<i>N</i>-Nitrosoguvacoline;3;Sup 7, 85;2004;
56894-91-8;1,4-Bis(chloromethoxymethyl)benzene;3;"15; Sup 7, 71";1999;
57018-52-7;1-<i>tert</i>-Butoxypropan-2-ol;3;88;2006;
57117-31-4;2,3,4,7,8-Pentachlorodibenzofuran;1;100F;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
57465-28-8;3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126);1;100F;2012;See Polychlorinated biphenyls, dioxin-like, with a TEF according to WHO
57835-92-4;4-Nitropyrene;2B;46, 105;2013;
59277-89-3;Aciclovir;3;76;2000;
59536-65-1;Polybrominated biphenyls;2A;41, Sup 7, 107;2016;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data, namely mechanistic similarity with polychlorinated biphenyls classified in Group 1
59820-43-8;HC Yellow No. 4;3;57;1993;
"59865-13-3<br/>
79217-60-0";Ciclosporin (see Cyclosporine);;;;
"59865-13-3<br/>
79217-60-0";Cyclosporine;1;50, 100A;2012;
60102-37-6;Petasitenine;3;31, Sup 7;1987;
60153-49-3;3-(<i>N</i>-Nitrosomethylamino)propionitrile;2B;Sup 7, 85;2004;
62450-06-0;Trp-P-1 (3-Amino-1,4-dimethyl-5<i>H</i>-pyrido[4,3-<i>b</i>]indole);2B;31, Sup 7;1987;
62450-07-1;Trp-P-2 (3-Amino-1-methyl-5<i>H</i>-pyrido[4,3-<i>b</i>]indole);2B;31, Sup 7;1987;
63041-90-7;6-Nitrobenzo[<i>a</i>]pyrene;3;Sup 7, 46;1989;
64436-13-1;Arsenobetaine and other organic arsenic compounds that are not metabolized in humans;3;100C;2012;
64742-93-4;Bitumens, occupational exposure to oxidized bitumens and their emissions during roofing;2A;103;2013;
65271-80-9;Mitoxantrone;2B;76;2000;
65996-93-2;Coal-tar pitch;1;35, Sup 7, 100F;2012;
66733-21-9;Erionite;1;42, Sup 7, 100C;2012;
67730-10-3;Glu-P-2 (2-Aminodipyrido[1,2-<i>a</i>:3',2'-<i>d</i>]imidazole);2B;40, Sup 7;1987;
67730-11-4;Glu-P-1 (2-Amino-6-methyldipyrido[1,2-<i>a</i>:3',2'-<i>d</i>]imidazole);2B;40, Sup 7;1987;
68006-83-7;MeA-alpha-C (2-Amino-3-methyl-9<i>H</i>-pyrido[2,3-<i>b</i>]indole);2B;40, Sup 7;1987;
68308-34-9;Shale oils;1;35, Sup 7, 100F;2012;
68603-42-9;Coconut oil diethanolamine condensate;2B;101;2013;
69655-05-6;Didanosine;3;76;2000;
71267-22-6;<i>N</i>'-Nitrosoanatabine (NAT);3;37, Sup 7, 89;2007;
73459-03-7;5-Methylangelicin plus ultraviolet A radiation;3;Sup 7;1987;
75321-20-9;1,3-Dinitropyrene;2B;46, 105;2013;
76180-96-6;IQ (2-Amino-3-methylimidazo[4,5-<i>f</i>]quinoline);2A;Sup 7, 56;1993;NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
77094-11-2;MeIQ (2-Amino-3,4-dimethylimidazo[4,5-<i>f</i>]quinoline);2B;Sup 7, 56;1993;
77439-76-0;3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5<i>H</i>)-furanone;2B;84;2004;
77500-04-0;MeIQx (2-Amino-3,8-dimethylimidazo[4,5-<i>f</i>]quinoxaline);2B;Sup 7, 56;1993;
82413-20-5;Droloxifene;3;66;1996;
83463-62-1;Bromochloroacetonitrile;3;52, 71;1999;
85502-23-4;3-(<i>N</i>-Nitrosomethylamino)propionaldehyde;3;Sup 7, 85;2004;
85878-62-2;Pyrido[3,4-<i>c</i>]psoralen;3;40, Sup 7;1987;
85878-63-3;7-Methylpyrido[3,4-<i>c</i>]psoralen;3;40, Sup 7;1987;
87625-62-5;Ptaquiloside;3;40, Sup 7;1987;
89778-26-7;Toremifene;3;66;1996;
90045-36-6;<i>Ginkgo biloba</i> extract;2B;108;2016;
90370-29-9;4,4',6-Trimethylangelicin plus ultraviolet A radiation;3;Sup 7;1987;
"90456-67-0 [deleted]<br/>
924-42-5";<i>N</i>-Methylolacrylamide;3;60;1994;
101043-37-2;Microcystin-LR;2B;94;2010;
105650-23-5;PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-<i>b</i>]pyridine);2B;56;1993;
105735-71-5;3,7-Dinitrofluoranthene;2B;46, 65, 105;2013;
111025-46-8;Pioglitazone;2A;108;2016;
111189-32-3;Naphtho[1,2-<i>b</i>]fluoranthene;3;92;2010;
116355-83-0;Fumonisin B<sub>1</sub>;2B;82;2002;
116355-83-0;<i>Fusarium moniliforme</i>, toxins derived from (fumonisin B<sub>1</sub>, fumonisin B<sub>2</sub>, and fusarin C);2B;56;1993;
118399-22-7;Nodularins;3;94;2010;
122320-73-4;Rosiglitazone;3;108;2016;
308068-56-6;Carbon nanotubes, multi-walled MWCNT-7;2B;111;In prep.;
308068-56-6;Carbon nanotubes, multi-walled, other than MWCNT-7;3;111;In prep.;
308068-56-6;Carbon nanotubes, single-walled;3;111;In prep.;
308068-56-6;Multi-walled carbon nanotubes MWCNT-7 (see Carbon nanotubes, multi-walled MWCNT-7);;;;
308068-56-6;Multi-walled carbon nanotubes other than MWCNT-7 (see Carbon nanotubes, multi-walled, other than MWCNT-7);;;;
308068-56-6;Single-walled carbon nanotubes (see Carbon nanotubes, single-walled);;;;
308076-74-6;Silicon carbide, fibrous;2B;111;In prep.;
409-21-2;Silicon carbide whiskers;2A;111;In prep.;
xxx;Acheson process, occupational exposure associated with;1;111;In prep.;
xxx;Acid mists, strong inorganic;1;54, 100F;2012;
xxx;Acrylic fibres;3;19, Sup 7;1987;
xxx;Acrylonitrile-butadiene-styrene copolymers;3;19, Sup 7;1987;
xxx;Alcoholic beverages;1;44, 96, 100E;2012;
xxx;<i>Aloe vera</i>, whole leaf extract;2B;108;2016;
xxx;Alpha particles (see Radionuclides);;;;
xxx;Aluminium production;1;34, Sup 7, 92, 100F;2012;
xxx;Anaesthetics, volatile;3;11, Sup 7;1987;
xxx;Androgenic (anabolic) steroids;2A;Sup 7;1987;
xxx;Areca nut;1;85, 100E;2012;
xxx;Art glass, glass containers and pressed ware (manufacture of);2A;58;1993;
xxx;Auramine production;1;Sup 7, 99, 100F;2012;
xxx;Benzidine, dyes metabolized to;1;99, 100F;2012;NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
xxx;Beta particles (see Radionuclides);;;;
xxx;Betel quid with tobacco;1;Sup 7, 85, 100E;2012;
xxx;Betel quid without tobacco;1;Sup 7, 85, 100E;2012;
xxx;Biomass fuel (primarily wood), indoor emissions from household combustion of;2A;95;2010;
xxx;Bisulfites;3;54;1992;
xxx;Bitumens, occupational exposure to hard bitumens and their emissions during mastic asphalt work;2B;103;2013;
xxx;BK polyomavirus (BKV);2B;104;2013;
xxx;Boot and shoe manufacture and repair (see Leather dust, Benzene);;25, Sup 7;1987;
xxx;Bracken fern;2B;40, Sup 7;1987;
xxx;Calcium carbide production;3;92;2010;
xxx;Carbon electrode manufacture;2A;92;2010;
xxx;Carpentry and joinery;2B;25, Sup 7;1987;
xxx;Ceramic implants;3;74;1999;
xxx;Chimney sweeping (see Soot);;92;2010;
xxx;Chlorinated drinking-water;3;52;1991;
xxx;Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60%;2B;48;1990;
xxx;Chlorophenols (see Polychlorophenols);;;;
xxx;Chlorophenoxy herbicides;2B;41, Sup 7;1987;
xxx;<i>Clonorchis sinensis</i> (infection with);1;61, 100B;2012;
xxx;Coal dust;3;68;1997;
xxx;Coal gasification;1;Sup 7, 92, 100F;2012;
xxx;Coal, indoor emissions from household combustion of;1;95, 100E;2012;
xxx;Coffee (drinking);3;51, 116;In prep.;NB: There is <i>evidence suggesting lack of carcinogenicity</i> in humans of coffee drinking for cancers of the pancreas, liver, female breast, uterine endometrium, and prostate.  Inverse associations with coffee drinking have been observed with cancers of the liver and uterine endometrium. 
xxx;Coke production;1;Sup 7, 92, 100F;2012;
xxx;Continuous glass filament (see Glass filament);;;;
xxx;Dental materials;3;74;1999;
xxx;Diesel engine exhaust (see Engine exhaust, diesel);;;;
xxx;Diesel fuel, marine;2B;45;1989;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
xxx;Diesel fuels, distillate (light);3;45;1989;
xxx;Dry cleaning (occupational exposures in);2B;63;1995;
xxx;Dyes metabolized to benzidine (see Benzidine, dyes metabolized to);;;;
xxx;Electric fields, extremely low-frequency;3;80;2002;
xxx;Electric fields, static;3;80;2002;
xxx;Engine exhaust, diesel;1;46, 105;2013;
xxx;Engine exhaust, gasoline;2B;46, 105;2013;
xxx;Epstein-Barr virus;1;70, 100B;2012;
xxx;Estrogen therapy, postmenopausal;1;72, 100A;2012;
xxx;Estrogen-progestogen menopausal therapy (combined);1;72, 91, 100A;2012;
xxx;Estrogen-progestogen oral contraceptives (combined);1;72, 91, 100A;2012;NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary
xxx;Firefighter (occupational exposure as a);2B;98;2010;
xxx;Fission products, including strontium-90;1;100D;2012;
xxx;Flat-glass and specialty glass (manufacture of);3;58;1993;
xxx;Fluorescent lighting;3;55;1992;
xxx;Fluoro-edenite fibrous amphibole;1;111;In prep.;
xxx;Foreign  bodies (see Ceramic implants, Dental materials, Implanted foreign bodies, Metallic implants, Organic polymeric materials, Orthopaedic implants, Polymeric implants, Silicone breast implants);;;;
xxx;;2A;95;2010;
xxx;Fuel oils, distillate (light);3;45;1989;
xxx;Fuel oils, residual (heavy);2B;45;1989;
xxx;Furniture and cabinet making (see Wood dust);;25, Sup 7;1987;
xxx;<i>Fusarium graminearum</i>, <i>F. culmorum</i>, and <i>F. crookwellense</i>, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X);3;Sup 7, 56;1993;
xxx;<i>Fusarium sporotrichioides</i>, toxins derived from (T-2 toxin);3;56;1993;
xxx;Gamma-Radiation (see X- and Gamma-Radiation);;;;
xxx;Gasoline;2B;45;1989;NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
xxx;Gasoline engine exhaust (see Engine exhaust, gasoline);;;;
xxx;Glass filament, continuous;3;43, 81;2002;
xxx;Goldenseal root powder;2B;108;2016;
xxx;Haematite mining (underground);1;1, Sup 7, 100D;2012;
xxx;Hair colouring products (personal use of);3;57, 99;2010;
xxx;Hairdresser or barber (occupational exposure as a);2A;57, 99;2010;
xxx;<i>Helicobacter pylori</i> (infection with);1;61, 100B;2012;
xxx;Hepatitis B virus (chronic infection with);1;59, 100B;2012;
xxx;Hepatitis C virus (chronic infection with);1;59, 100B;2012;
xxx;Hepatitis D virus;3;59;1994;
xxx;Hexachlorocyclohexanes;2B;20, Sup 7;1987;
xxx;High-temperature frying (see Frying);;;;
xxx;Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of);;;;
xxx;Household combustion of coal (see Coal, indoor emissions from household combustion);;;;
xxx;Human herpesvirus type 4 (see Epstein-Barr virus);;;;
xxx;Human herpesvirus type 8 (see Kaposi sarcoma herpesvirus);;;;
xxx;Human immunodeficiency virus type 1 (infection with);1;67, 100B;2012;
xxx;Human immunodeficiency virus type 2 (infection with);2B;67;1996;
xxx;Human papillomavirus genus beta (except types 5 and 8) and genus gamma;3;90, 100B;2012;
xxx;Human papillomavirus type 68;2A;100B;2012;
xxx;Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59;1;64, 90, 100B;2012;NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer
xxx;Human papillomavirus types 26, 53, 66, 67, 70, 73, 82;2B;100B;2012;
xxx;Human papillomavirus types 30, 34, 69, 85, 97;2B;100B;2012;NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1
xxx;Human papillomavirus types 5 and 8 (in patients with epidermodysplasia verruciformis);2B;100B;2012;
xxx;Human papillomavirus types 6 and 11;3;90, 100B;2012;
xxx;Human T-cell lymphotropic virus type I;1;67, 100B;2012;
xxx;Human T-cell lymphotropic virus type II;3;67;1996;
xxx;Hypochlorite salts;3;52;1991;
xxx;Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based, and titanium-based alloys, stainless steel and depleted uranium ;3;74;1999;
xxx;Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium, and 7% iron;2B;74;1999;
xxx;Insulation glass wool;3;43, 81;2002;
xxx;Involuntary smoking (see Tobacco smoke, second-hand);;;;
xxx;Ionizing radiation (all types);1;100D;2012;
xxx;Iron and steel founding (occupational exposure during);1;34, Sup 7, 100F;2012;
xxx;Isopropyl alcohol manufacture using strong acids;1;Sup 7, 100F;2012;
xxx;Isopropyl oils;3;15, Sup 7, 71;1999;
xxx;JC polyomavirus (JCV);2B;104;2013;
xxx;Jet fuel;3;45;1989;
xxx;Kaposi sarcoma herpesvirus;1;70, 100B;2012;
xxx;Lead compounds, inorganic;2A;Sup 7, 87;2006;
xxx;Lead compounds, organic;3;23, Sup 7, 87;2006;NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead
xxx;Leather dust;1;100C;2012;
xxx;Leather goods manufacture;3;25, Sup 7;1987;
xxx;Leather tanning and processing;3;25, Sup 7;1987;
xxx;Lumber and sawmill industries (including logging);3;25, Sup 7;1987;
xxx;Madder root (<i>Rubia tinctorum</i>);3;82;2002;
xxx;Magenta production;1;Sup 7, 57, 99, 100F;2012;
xxx;Magnetic fields, extremely low-frequency;2B;80;2002;
xxx;Magnetic fields, static;3;80;2002;
xxx;Malaria (caused by infection with <i>Plasmodium falciparum</i> in holoendemic areas);2A;104;2013;
xxx;Mate, not very hot (drinking);3;51, 116;In prep.;
xxx;Mate, hot (see Very hot beverages);;;;
xxx;Merkel cell polyomavirus (MCV);2A;104;2013;
xxx;Metabisulfites;3;54;1992;
xxx;Metallic implants prepared as thin smooth films;2B;74;1999;
xxx;Methylmercury compounds;2B;58;1993;NB: Evaluated as a group
xxx;<i>Microcystis</i> extracts;3;94;2010;
xxx;Mineral oils, highly-refined;3;33, Sup 7;1987;
xxx;Mineral oils, untreated or mildly treated;1;33, Sup 7, 100F;2012;
xxx;Modacrylic fibres;3;19, Sup 7;1987;
xxx;MOPP and other combined chemotherapy including alkylating agents;1;Sup 7, 100A;2012;
xxx;Neutron radiation;1;75, 100D;2012;NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
xxx;Nickel compounds;1;Sup 7, 49, 100C;2012;
xxx;Nickel refining (see Nickel compounds);;11;1976;
xxx;Nitrate or nitrite (ingested) under conditions that result in endogenous nitrosation;2A;94;2010;
xxx;Non-arsenical insecticides (occupational exposures in spraying and application of);2A;53;1991;
xxx;Oestrogen (see Estrogen);;;;
xxx;<i>Opisthorchis felineus</i> (infection with);3;61;1994;
xxx;<i>Opisthorchis viverrini</i> (infection with);1;61, 100B;2012;
xxx;Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives);;;;
xxx;Organic polymeric materials;3;74;1999;
xxx;Orthopaedic implants of complex composition and cardiac pacemakers;3;74;1999;
xxx;Outdoor air pollution;1;109;2016;
xxx;Outdoor air pollution, particulate matter in;1;109;2016;
xxx;Paint manufacture (occupational exposure in);3;47;1989;
xxx;Painter (occupational exposure as a);1;47, 98, 100F;2012;
xxx;Particulate matter in outdoor air pollution (see Outdoor air pollution, particulate matter in);;;;
xxx;Paving and roofing with coal-tar pitch (see Coal-tar pitch);;35, Sup 7, 92, 100F;2010;
xxx;Petroleum refining (occupational exposures in);2A;45;1989;
xxx;Petroleum solvents;3;47;1989;
xxx;Phenacetin, analgesic mixtures containing;1;Sup 7, 100A;2012;
xxx;Pickled vegetables (traditional Asian);2B;56;1993;
xxx;Polychlorinated biphenyls, dioxin-like, with a Toxicity Equivalency Factor (TEF) according to WHO (PCBs 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, 189);1;107;2016;NB: Overall evaluation upgraded to Group 1 with strong supporting evidence from other relevant data
xxx;Polychlorinated dibenzofurans (see 2,3,4,7,8-Pentachlorodibenzofuran);3;69;1997;
xxx;Polychlorinated dibenzo-<i>para</i>-dioxins (other than 2,3,7,8-tetrachlorodibenzo-<i>para</i>-dioxin);3;69;1997;
xxx;"Polychlorophenols and their sodium salts (mixed exposures) (see Pentachlorophenol; 2,4,6-Trichlorophenol )";2B;53, 71;1999;
xxx;Polymeric implant prepared as thin smooth films (with the exception of poly-glycolic acid);2B;74;1999;
xxx;Printing inks;3;65;1996;
xxx;Printing processes (occupational exposures in);2B;65;1996;
xxx;Processed meat (consumption of);1;114;In prep.;
xxx;Proflavine salts;3;24, Sup 7;1987;
xxx;Progestins;2B;Sup 7;1987;
xxx;Progestogen-only contraceptives;2B;72;1999;
xxx;Pulp and paper manufacture;3;25, Sup 7;1987;
xxx;Radiofrequency electromagnetic fields;2B;102;2013;
xxx;Radioiodines, including iodine-131;1;78, 100D;2012;
xxx;Radionuclides, alpha-particle-emitting, internally deposited;1;78, 100D;2012;NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
xxx;Radionuclides, beta-particle-emitting, internally deposited;1;78, 100D;2012;NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
xxx;Red meat (consumption of);2A;114;In prep.;
xxx;Refractory ceramic fibres;2B;43, 81;2002;
xxx;Rock (stone) wool;3;43, 81;2002;
xxx;Rubber manufacturing industry;1;28, Sup 7, 100F;2012;
xxx;Salted fish, Chinese-style;1;56, 100E;2012;
xxx;<i>Schistosoma haematobium</i> (infection with);1;61, 100B;2012;
xxx;<i>Schistosoma japonicum</i> (infection with);2B;61;1994;
xxx;<i>Schistosoma mansoni</i> (infection with);3;61;1994;
xxx;Shiftwork that involves circadian disruption;2A;98;2010;
xxx;Silicone breast implants;3;74;1999;
xxx;Slag wool;3;43, 81;2002;
xxx;Solar radiation;1;55, 100D;2012;
xxx;Soot (as found in occupational exposure of chimney sweeps);1;35, Sup 7, 92, 100F;2012;
xxx;Special-purpose fibres such as E-glass and '475' glass fibres;2B;81;2002;
xxx;Sulfites;3;54;1992;
xxx;Sunlamps and sunbeds (see Ultraviolet-emitting tanning devices);;;;
xxx;Surgical implants (see Ceramic implants, Dental materials, Implanted foreign bodies, Metallic implants, Organic polymeric materials, Orthopaedic implants, Polymeric implants, Silicone breast implants);;;;
xxx;SV40 polyomavirus ;3;104;2013;
xxx;Tea;3;51;1991;
xxx;Tetrakis(hydroxymethyl)phosphonium salts;3;48, 71;1999;
xxx;Textile manufacturing industry (work in);2B;48;1990;
xxx;Tobacco smoke, second-hand;1;83, 100E;2012;
xxx;Tobacco smoking;1;83, 100E;2012;
xxx;Tobacco, smokeless;1;Sup 7, 89, 100E;2012;
xxx;Toxins derived from certain <i>Fusarium</i> species (see <i>Fusarium</i>);;;;
xxx;Ultraviolet radiation (wavelengths 100-400 nm, encompassing UVA, UVB, and UVC);1;55, 100D;2012;
xxx;Ultraviolet-emitting tanning devices;1;100D;2012;
xxx;Urethane (see Ethyl carbamate);;;;
xxx;Very hot beverages at above 65 °C (drinking);2A;116;In prep.;
xxx;Welding fumes;2B;49;1990;NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders
xxx;Wood dust;1;62, 100C;2012;
xxx;Wood smoke (see Biomass fuel, indoor emissions from household combustion);;;;
xxx;X- and Gamma-Radiation;1;75, 100D;2012;
